Synapse - Debra Sarasohn

Results (21)

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

Journal Article

Suidan, R. S.; Ramirez, P. T.; Sarasohn, D. M.; Teitcher, J. B.; Mironov, S.; Iyer, R. B.; Zhou, Q.; Iasonos, A.; Paul, H.; Hosaka, M.; more...
Gynecologic Oncology (2014)

Fulltext@MSK | Save

Stage IB1 cervical cancer: Role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy

Journal Article

Lakhman, Y.; Akin, O.; Park, K. J.; Sarasohn, D. M.; Zheng, J.; Goldman, D. A.; Sohn, M. J.; Moskowitz, C. S.; Sonoda, Y.; Hricak, H.; more...
Radiology (2013)

Fulltext@MSK | Save

Role of preoperative MRI in improving the selection of patients with early-stage cervical cancer for fertility-sparing surgery

Meeting Abstract

Lakhman, Y.; Akin, O.; Park, K.; Zheng, J.; Sohn, M.; Moskowitz, C.; Sarasohn, D.; Sonoda, Y.; Hricak, H.; Abu Rustum, N.
Gynecologic Oncology (2012)

Fulltext@MSK | Save

Implementation of evidence-based guidelines for thyroid nodule biopsy: A model for establishment of practice standards

Journal Article

Hambly, N. M.; Gonen, M.; Gerst, S. R.; Li, D.; Jia, X.; Mironov, S.; Sarasohn, D.; Fleming, S. E.; Hann, L. E.
American Journal of Roentgenology (2011)

Fulltext@MSK | Save

Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-hodgkin lymphoma

Journal Article

Gerecitano, J.; Portlock, C.; Hamlin, P.; Moskowitz, C. H.; Noy, A.; Straus, D.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes

Journal Article

O'Connor, O. A.; Portlock, C.; Moskowitz, C.; Hamlin, P.; Straus, D.; Gerecitano, J.; Gonen, M.; Dumitrescu, O.; Sarasohn, D.; Butos, J.; more...
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): Final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas

Meeting Abstract

Gerecitano, J.; Portlock, C. S.; Hamlin, P. A.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
Blood (2009)

Fulltext@MSK | Save

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

Journal Article

O'Connor, O. A.; Horwitz, S.; Hamlin, P.; Portlock, C.; Moskowitz, C. H.; Sarasohn, D.; Neylon, E.; Mastrella, J.; Hamelers, R.; Macgregor-Cortelli, B.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre phase 2 clinical trial